Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03275597
Recruitment Status : Active, not recruiting
First Posted : September 7, 2017
Last Update Posted : August 26, 2021
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
University of Wisconsin, Madison

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : July 2022
Estimated Study Completion Date : July 2025